|
posters
Mechanisms
of HIV Drug Resistance
HIV-1
reverse transcriptase mutations that suppress zidovudine resistance
also increase in vitro susceptibility to tenofovir, but not
stavudine
NT Parkin
Prevalence
and quantitative phenotypic resistance patterns of specific
nucleoside analogue mutation combinations and of mutations
44 and 118 in reverse transcriptase in a large dataset of
recent HIV-1 clinical isolates
M Van Houtte
Identification
of a clinical reverse transcriptase backbone that improves
replication of a non-nucleoside reverse transcriptase inhibitor-resistant
mutant by increasing the rate of polymerization
LM Demeter
Non-nucleoside
reverse transcriptase inhibitor hypersusceptibility can be
demonstrated in multicycle phenotype assays and in inhibition
assays of purified HIV-1 reverse transcriptases
NS Shulman
Genetic
correlates of phenotypic hypersusceptibility to efavirenz
among 446 baseline isolates from five ACTG studies
NS Shulman
The
HIV-1 protease mutation K55R is associated with the presence
of the M46I/L mutation
E Morgan
Search
for polymorphic sites in R5 tropic HIV-1 Env and enfuvirtide
drug susceptibility in baseline isolates from TORO 1 &
TORO 2
C Su
|
